Vitruvian Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US
Rajmohan Neervannan(Related person at the time of the offering.)Raj Neervannan(Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Founder)inKiva Kolstein(President & Chief Revenue Officer)inHeather Zynczak(Chief Marketing Officer)in
Co-investorsAlkeon InnovationBlue Owl CapitalBond Capital ManagementBrama One VenturesCapitalGCentana Growth Partners+12 more
Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health.
BiotechDigital HealthHealthtechWellness & FitnessBoston, US
Yishai Zohar(Director, President, and Chief Executive Officer)inElliot Maltz(Treasurer)in
BoardJohn LaMattina(Director)Elon Boms(Director)inMeghan Fitzgerald(Director)Robert Forrester(Director)in
Co-investorsHercules Capital, Inc.LaunchCapitalSalica InvestmentsCapstar VenturesInvescoOrbiMed+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














